Understanding hirsutism diagnosis, causes, and treatment? Find information on hirsutism ICD-10 code, medical coding, clinical documentation, and differential diagnosis. Explore healthcare resources for hirsutism treatment options, including medication and management strategies. Learn about hirsutism symptoms, signs, and associated conditions for accurate diagnosis and effective patient care. This resource provides valuable information for healthcare professionals, clinicians, and patients seeking to understand hirsutism.
Also known as
Hypertrichosis
Abnormal hair growth, including hirsutism.
Other adrenal disorders
Includes adrenal causes of hirsutism like Cushings.
Other ovarian dysfunction
Encompasses ovarian conditions that can cause hirsutism like PCOS.
Polycystic ovary syndrome
PCOS is a common hormonal disorder causing hirsutism in women.
When to use each related code
| Description |
|---|
| Excessive male-pattern hair growth in women. |
| Polycystic ovary syndrome (PCOS) |
| Congenital adrenal hyperplasia (CAH) |
Coding L68.9 (Hirsutism, unspecified) without documenting underlying cause when known creates compliance risks and impacts reimbursement.
Failing to code drug-induced hirsutism (L68.0) when applicable leads to inaccurate data and potential patient safety issues.
Incorrectly coding hirsutism associated with PCOS (E28.2) instead of using combination codes for both conditions impacts data integrity and quality reporting.
Patient presents with hirsutism, characterized by excessive male-pattern hair growth in a female. The patient reports unwanted, coarse terminal hair growth in androgen-sensitive areas, including the face (chin, upper lip), chest, back, and abdomen. Onset and progression of hair growth were documented and reviewed. The Ferriman-Gallwey score was calculated to assess the severity of hirsutism. Differential diagnoses considered include polycystic ovary syndrome (PCOS), congenital adrenal hyperplasia (CAH), Cushing's syndrome, and androgen-secreting tumors. Laboratory tests, including serum androgen levels (testosterone, DHEA-S, androstenedione), luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, 17-hydroxyprogesterone, and thyroid function tests, were ordered to evaluate for underlying endocrine disorders. Patient's medical history, family history, and current medications were reviewed. The patient denies any use of androgenic medications. The initial treatment plan includes lifestyle modifications such as diet and exercise, as well as potential pharmacologic interventions like oral contraceptives, antiandrogens (spironolactone, finasteride), or topical treatments (eflornithine hydrochloride). Patient education regarding the causes, treatment options, and expected outcomes of hirsutism management was provided. Follow-up appointment scheduled to monitor treatment response and adjust therapy as needed. ICD-10 code L68.0, Excessive hair growth, was assigned.